Showing 1 - 4 results of 4 for search 'Pilar Guerra-García', query time: 0.03s Refine Results
  1. 1
    Younger age and induction failure predict outcomes in infant leukemia: 30 years of experience in a tertiary center

    Younger age and induction failure predict outcomes in infant leukemia: 30 years of experience in a tertiary center by Bárbara Ochoa-Fernández, Víctor Galán-Gómez, Pilar Guerra-García, Pilar Guerra-García, Sonsoles Sanromán, Sonsoles Sanromán, Isabel Martínez, David Bueno, David Bueno, Yasmina Mozo, Luisa Sisinni, Itsaso Losantos, Berta González, Berta González, Antonio Pérez-Martínez, Antonio Pérez-Martínez

    Published 2023-05-01
    Get full text
    Article
  2. 2
    Haploidentical vs. HLA-matched donor hematopoietic stem-cell transplantation for pediatric patients with acute lymphoblastic leukemia in second remission: A collaborative retrospective study of the Spanish Group for Bone Marrow Transplantation in Children (GETMON/GETH) and the Spanish Childhood Relapsed ALL Board (ReALLNet)

    Haploidentical vs. HLA-matched donor hematopoietic stem-cell transplantation for pediatric patients with acute lymphoblastic leukemia in second remission: A collaborative retrospec... by Celia Moreno, Eduardo Ramos-Elbal, Pablo Velasco, Yurena Aguilar, Berta Gonzáález Martínez, Carolina Fuentes, Águeda Molinos, Pilar Guerra-García, Pilar Guerra-García, Pilar Palomo, Jaime Verdu, Rosa María Adán Pedroso, José Manuel Vagace, Mónica López-Duarte, Alexandra Regueiro, María Tasso, José Luis Dapena, José Luis Dapena, José Antonio Salinas, Samuel Navarro, Francisco Bautista, Álvaro Lassaletta, Francisco Lendínez, Susana Rives, Susana Rives, Antonia Pascual, Antonia Rodríguez, José María Pérez-Hurtado, José María Fernández, Antonio Pérez-Martínez, Marta González-Vicent, Cristina Díaz de Heredia, José Luis Fuster, José Luis Fuster

    Published 2023-03-01
    Get full text
    Article
  3. 3
    CD19+ lineage chimerism, an early biomarker after anti-CD19 CAR-T cell therapy in patients previously receiving a hematopoietic stem cell transplantation

    CD19+ lineage chimerism, an early biomarker after anti-CD19 CAR-T cell therapy in patients previously receiving a hematopoietic stem cell transplantation by Isabel Martínez-Romera, Víctor Galán-Gómez, Berta González-Martínez, Pilar Guerra García, Sonsoles San Román Pacheco, Dolores Corral Sánchez, Yasmina Mozo del Castillo, David Bueno Sánchez, Luisa Sisinni, Alba González Guerrero, Serafin Castellano Dámaso, Elena Sánchez Zapardiel, Beatriz Ruz Caracuel, Antonio Balas Pérez, Antonio Pérez-Martínez, Antonio Pérez-Martínez, Antonio Pérez-Martínez

    Published 2022-08-01
    Get full text
    Article
  4. 4
    The phase I RELEASE clinical trial to evaluate the safety of NK cells in COVID-19

    The phase I RELEASE clinical trial to evaluate the safety of NK cells in COVID-19 by Clara Hernández-Blanco, Karima Al-Akioui-Sanz, Lara Herrera, Cristina Aguirre-Portolés, Daniel Lozano-Ojalvo, Leticia Pérez-Rodriguez, Jordi Cano-Ochando, Pilar Guerra-García, Alejandro Martín-Quirós, José Luis Vicario, Silvia Santos, Miguel Ángel Pérez-Vaquero, Miguel Ángel Vesga, Alberto M. Borobia, Antonio J. Carcas, Antonio Balas, Miguel Ángel Moreno, Rebeca Pérez de Diego, Mercedes Gasior, Bernat Soria, Cristina Eguizabal, Antonio Pérez-Martínez

    Published 2025-02-01
    Get full text
    Article

Search Tools: